<DOC>
	<DOCNO>NCT02295046</DOCNO>
	<brief_summary>This study assess bioequivalence Amlodipine besylate/Atorvastatin calcium Tablets 10mg/80mg Dr. Reddy 's Laboratories Limited , India CADUETÂ® ( amlodipine besylate atorvastatin calcium ) tablets 10mg/80mg Pfizer Ireland Pharmaceuticals Dublin , Ireland Healthy Male Female Volunteers Fasting condition .</brief_summary>
	<brief_title>Bioavailability Study Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition</brief_title>
	<detailed_description>Open label , randomize , two-treatment , two-period , two-sequence , crossover , single dose , oral bioequivalence study Amlodipine besylate/Atorvastatin calcium Tablets 10mg/80mg Fasting condition .</detailed_description>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Amlodipine , atorvastatin drug combination</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Healthy male female volunteer 18 55 year age 2 . Subject Body Mass Index within 18.5 24.9 kg/m2 , weight less 50 kg 3 . Normal health determine personal medical history , haematology , clinical chemistry urinalysis laboratory profile 4 . Non smokers exsmokers give smoke least two year prior study 5 . The subject agree abstain alcohol , food drink contain methylxanthines ( tea , cola , chocolate ) 48 hour prior study drug administration study period grapefruitcontaining food beverage 48 hour prior study drug administration study period 6 . Ability understand full nature purpose study , include possible risk side effect ; ability cooperate Clinical Investigator comply requirement entire study 7 . Informed write consent give voluntary initiation prestudy screen 8 . Negative result HIV , hepatitis C hepatitis B test 9 . Negative result pregnancy test ( female subject ) 10 . Nonlactating woman ( female subject ) 11 . Subjects use nonhormonal contraceptive measure study ( female subject ) 12 . Normal creatine phosphokinase ( CPK ) level time checkin period . 1 . History hypersensitivity test drug ( Amlodipine Besylate/Atorvastatin Calcium ) drug belong pharmacological chemical class inactive ingredient formulation 2 . Participation clinical study investigational product precede three month clinical study generic product precede two month 3 . Hospitalization reason within eight week prior study initiation 4 . Donation 450 ml blood , within eight week prior study initiation 5 . Intake prescription nonprescription drug ( include antiacid , analgesic , statin , cyclosporin , fibric acid derivative , erythromycin , azole antifungal , niacin , oral contraceptive etc . ) two week precede study throughout study 6 . History presence relevant medical condition include cancer , significant disease renal , hepatic , immunological , dermatological , gastrointestinal , respiratory , cardiovascular , endocrine locomotor system , metabolic , haematological neurological disorder psychiatric disorder 7 . History presence drug alcohol abuse , within past year 8 . History current condition disease know interfere absorption , distribution , metabolism excretion investigational medicine 9 . ECG evidence clinically significant abnormality 10 . Presence acute chronic infectious disease 11 . Positive result HIV , hepatitis C hepatitis B test 12 . Positive result breath alcohol test drug abuse check 13 . Positive result pregnancy test ( female subject ) 14 . Subject vegetarian follow particular diet 15 . A history difficulty donate blood .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>